SCI Abstract

search
+
Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing
Active surveillance selection and 3-year durability in intermediate-risk prostate cancer following genomic testing
Genomic testing can add risk stratification information to clinicopathological features in prostate cancer, aiding in shar...
Use of a Schelin catheter for transurethral intraprostatic anesthesia (TUIA) prior to iTIND procedure
Use of a Schelin catheter for transurethral intraprostatic anesthesia (TUIA) prior to iTIND procedure
Endorsing the principles of minimal invasiveness in benign-prostatic hyperplasia (BPH) surgery, we conducted the first eva...
Associations between glucocorticoid use and major adverse cardiovascular events in patients with prostate cancer receiving antiandrogen: a retrospective cohort study
Associations between glucocorticoid use and major adverse cardiovascular events in patients with prostate cancer receiving antiandrogen: a retrospective cohort study
Prednisolone/prednisone coadministration with abiraterone may explain abiraterone-related increase in cardiovascular risk....
MRI accuracy for recurrence after partial gland ablation with HIFU for localized prostate cancer. A systematic review and meta-analysis
MRI accuracy for recurrence after partial gland ablation with HIFU for localized prostate cancer. A systematic review and meta-analysis
Prostate cancer remains the most frequently diagnosed cancer among men. High-Intensity Focused Ultrasound (HIFU) has emerg...
Real-world outcomes following biochemical recurrence after definitive therapy with a short prostate-specific antigen doubling time: potential role of early secondary treatment
Real-world outcomes following biochemical recurrence after definitive therapy with a short prostate-specific antigen doubling time: potential role of early secondary treatment
The natural history of biochemical recurrence (BCR) managed with delayed hormonal therapy is well documented by data from ...
Salvage therapies for biochemical recurrence after definitive local treatment: a systematic review, meta-analysis, and network meta-analysis
Salvage therapies for biochemical recurrence after definitive local treatment: a systematic review, meta-analysis, and network meta-analysis
Recent advancements in the management of biochemical recurrence (BCR) following local treatment for prostate cancer (PCa),...
Ejaculatory function after radiotherapy for prostate cancer: a systematic review and meta-analysis
Ejaculatory function after radiotherapy for prostate cancer: a systematic review and meta-analysis
Scant data exists on the impacts of prostate radiation on ejaculatory function. We performed a systematic review and meta-...
Whole-body magnetic resonance imaging for staging patients with high-risk prostate cancer
Whole-body magnetic resonance imaging for staging patients with high-risk prostate cancer
Staging patients with high-risk prostate cancer (HRPCa) with conventional imaging of computed tomography (CT) and bone sci...
Prevalence and determinants of shared decision-making for PSA testing in the United States
Prevalence and determinants of shared decision-making for PSA testing in the United States
Shared decision-making (SDM) is recommended for prostate-specific antigen (PSA) testing but appears underutilized. This po...
Prevalence and determinants of shared decision-making for PSA testing in the United States
Prevalence and determinants of shared decision-making for PSA testing in the United States
Shared decision-making (SDM) is recommended for prostate-specific antigen (PSA) testing but appears underutilized. This po...
Editorial comment on “Reevaluating ‘Top-Down’ HoLEP: the case for anterior fibromuscular stroma as a surgical landmark”
The scientific community greatly benefits from diverse perspectives and vigorous discussions. In thei...
Benign prostatic hyperplasia during active surveillance for prostate cancer: is it time to define management strategies?
Benign prostatic hyperplasia during active surveillance for prostate cancer: is it time to define management strategies?
Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R, et al. Prostate cancer, version 4.2023, NCCN clinical practi...
Benign prostatic hyperplasia during active surveillance for prostate cancer: is it time to define management strategies?
Benign prostatic hyperplasia during active surveillance for prostate cancer: is it time to define management strategies?
Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R, et al. Prostate cancer, version 4.2023, NCCN clinical practi...
Two-year long-term follow-up of treatment with the Optilume BPH catheter system in a randomized controlled trial for benign prostatic hyperplasia (The PINNACLE Study)
Two-year long-term follow-up of treatment with the Optilume BPH catheter system in a randomized controlled trial for benign prostatic hyperplasia (The PINNACLE Study)
Patient outcomes were assessed 2 years after treatment with the Optilume BPH Catheter System, a minimally invasive surgica...
Two-year long-term follow-up of treatment with the Optilume BPH catheter system in a randomized controlled trial for benign prostatic hyperplasia (The PINNACLE Study)
Two-year long-term follow-up of treatment with the Optilume BPH catheter system in a randomized controlled trial for benign prostatic hyperplasia (The PINNACLE Study)
Patient outcomes were assessed 2 years after treatment with the Optilume BPH Catheter System, a minimally invasive surgica...
Incidence and management of BPH surgery-related urethral stricture: results from a large U.S. database
Incidence and management of BPH surgery-related urethral stricture: results from a large U.S. database
Urethral stricture (US) is a well-known complication after surgical treatment of benign prostatic hyperplasia (BPH). This ...
Incidence and management of BPH surgery-related urethral stricture: results from a large U.S. database
Incidence and management of BPH surgery-related urethral stricture: results from a large U.S. database
Urethral stricture (US) is a well-known complication after surgical treatment of benign prostatic hyperplasia (BPH). This ...
Baseline serum testosterone and differential efficacy of bipolar androgen therapy and enzalutamide in the randomized TRANSFORMER trial
Baseline serum testosterone and differential efficacy of bipolar androgen therapy and enzalutamide in the randomized TRANSFORMER trial
Bipolar androgen therapy (BAT) is effective in a subset of metastatic castration-resistant prostate cancer (mCRPC) patient...
Baseline serum testosterone and differential efficacy of bipolar androgen therapy and enzalutamide in the randomized TRANSFORMER trial
Baseline serum testosterone and differential efficacy of bipolar androgen therapy and enzalutamide in the randomized TRANSFORMER trial
Bipolar androgen therapy (BAT) is effective in a subset of metastatic castration-resistant prostate cancer (mCRPC) patient...
Accuracy, readability, and understandability of large language models for prostate cancer information to the public
Accuracy, readability, and understandability of large language models for prostate cancer information to the public
Generative Pretrained Model (GPT) chatbots have gained popularity since the public release of ChatGPT. Studies have evalua...
Accuracy, readability, and understandability of large language models for prostate cancer information to the public
Accuracy, readability, and understandability of large language models for prostate cancer information to the public
Generative Pretrained Model (GPT) chatbots have gained popularity since the public release of ChatGPT. Studies have evalua...
Letter to the editor: “Incidence of prostate cancer in transgender women in the US: a large database analysis.”
The opinions expressed by the authors are their own and this material should not be interpreted as representing the offici...
Correction: Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthcare claims and utilization study
The article Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthca...
The effects of glycemic index on prostate cancer progression in a xenograft mouse model
The effects of glycemic index on prostate cancer progression in a xenograft mouse model
Previously, we found low-carbohydrate diets slowed prostate cancer (PC) growth and increased survival vs. a Western diet i...
High-risk biochemical recurrence of locally treated prostate cancer after EMBARK. An end to decades of conventional wisdom?
Managing biochemical recurrence (BCR) of localized prostate cancers (PCa) that have failed all option...
Real-world prevalence of homologous recombination repair mutations in advanced prostate cancer: an analysis of two clinico-genomic databases
Real-world prevalence of homologous recombination repair mutations in advanced prostate cancer: an analysis of two clinico-genomic databases
Homologous recombination repair mutation (HRRm) status may guide risk-stratification and treatment decisions, including po...
Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer
Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer
Identification of emerging molecular biomarkers on circulating tumor cells (CTCs) represents an attractive feature of liqu...
Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort study
Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort study
While the cardiovascular risks of androgen receptor pathway inhibitors have been studied, they were seldom compared direct...
Impact of medical treatment on storage and voiding LUTS, nocturia, and quality of life in men at risk for progression
Prostate enlargement is a very common pathologic condition [1]: male aging process is associated with...
Reevaluating ‘Top-Down’ HoLEP: the case for anterior fibromuscular stroma as a surgical landmark
Elmansy H, Abbas L, Fathy M, Hodhod A, Shabana W, Alkandari A, et al. Top-down holmium laser enucleation of the prostate (...
Load More
format_indent_increase